Blood Advances Talks

Naive T-cell depletion in stem cell transplantation

Show Notes

Allogeneic hematopoietic stem cell transplantation (HCT) is curative in many patients with advanced hematopoietic malignancies. Donor T cells not only facilitate engraftment and protect against opportunistic pathogens and residual disease, but can also cause graft-versus-host disease (GVHD), with significant morbidity and mortality. 

What is Blood Advances Talks?

Blood Advances, a Journal of the American Society of Hematology, provides an open international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences.

Music for Blood Advances Talks is preformed by the Art Topilow Trio